Search for: "Eli Lilly and Company "
Results 81 - 100
of 1,165
Sort by Relevance
|
Sort by Date
17 Feb 2021, 1:40 pm
Besides Xeljanz, there are two other JAK inhibitors approved by the FDA: Olumiant (baricitinib) from Eli Lilly & Co.; and, Rinvoq (upadacitinib) from AbbVie. [read post]
8 Feb 2021, 9:16 am
This time the action brought by Eli Lilly on French territory concerns the same drug but is directed against another generic commercialized by Zentiva. [read post]
29 Jan 2021, 10:26 am
Eli Lilly’s antibody seems to fare poorly against the South African variant (B.1351), though testing is underway. [read post]
29 Jan 2021, 7:20 am
On 20 January 2021 Birss J handed down what may be his last first instance decision before he takes his place in the Court of Appeal. [read post]
4 Jan 2021, 9:04 pm
Ractopamine is owned by Elanco, a subsidiary of the pharmaceutical company Eli Lilly and Co. [read post]
21 Dec 2020, 2:56 pm
The outcome: Apotex, Inc. appeals from the judgment of the district court in a patent-infringement suit brought by Eli Lilly & Company under the Hatch-Waxman Act, 21 U.S.C. [read post]
21 Dec 2020, 10:16 am
Eli Lilly and Co v. [read post]
19 Nov 2020, 7:25 am
Furthermore, the Court stated that the promise to grant FRAND licnses to potential licensees made by SEPs holders pursuant to article 6.1 of the ETSI rules constituted a “stipulation pour autrui” (i.e. a third party beneficiary clause) that creates a direct contractual relationship between an ETSI member company (the SEPs holder) and a third party (a potential licensee, whether or not it is an ETSI member company). [read post]
12 Nov 2020, 9:05 pm
Food and Drug Administration (FDA) authorized the use of bamlanivimab, a COVID-19 antibody treatment developed by pharmaceutical company Eli Lilly. [read post]
10 Nov 2020, 5:45 am
November 9, 2020 also saw the FDA’s issuance of an EUA for Eli Lilly’s antibody treatment for COVID-19. [read post]
6 Nov 2020, 7:16 am
” (quoting appellant’s brief); See also Eli Lilly and Co. v. [read post]
29 Oct 2020, 2:22 am
And so, yet another win for Eli Lilly was secured. [read post]
26 Oct 2020, 6:00 am
A chemical engineer for six years with 3M and Eli Lilly before attending law school, she later served as managing patent counsel at The Coca-Cola Company in Atlanta, where she was responsible for the development and implementation of the company’s global patent strategy and for providing day-to-day advice and counseling to business stakeholders. [read post]
26 Oct 2020, 3:00 am
A chemical engineer for six years with 3M and Eli Lilly before attending law school, she later served as managing patent counsel at The Coca-Cola Company in Atlanta, where she was responsible for the development and implementation of the company’s global patent strategy and for providing day-to-day advice and counseling to business stakeholders. [read post]
26 Oct 2020, 2:49 am
Joining the majority of European courts, the Paris Court of Justice ruled that Eli Lilly’s patent, which relates to the combined administration of pemetrexed disodium and vitamin B12, was infringed by the marketing of Fresenius’ pemetrexed diacid. [read post]
25 Oct 2020, 6:00 pm
Daly, Crowley, Mofford & Durkee, LLP LSI Solutions Hanley, Flight & Zimmerman, LLC–Patent Associate Attorney Hanley, Flight & Zimmerman, LLC–Trademark Attorney Eli Lilly and Company–Patent Research Consultant Eli Lilly and Company–Patent Counsel Duane Morris LLP [read post]
18 Oct 2020, 6:00 pm
Jonas Anderson: Nonexcludable Surgical Method Patents (Source: SSRN) Cody Johnson: Intellectual Property and the Law of Fracking Fluid Disclosures: Tensions and Trends (Source: SSRN) New Job Postings on Patently-O: Daly, Crowley, Mofford & Durkee, LLP LSI Solutions Hanley, Flight & Zimmerman: Patent Associate Attorney Hanley, Flight & Zimmerman: Trademark Attorney AMPACC Law Group, PLLC Eli Lilly and Company: Patent Research Consultant Eli… [read post]
8 Oct 2020, 5:06 am
The French Tribunal Judiciaire de Paris has awarded record damages, in the amount to €28,000,000, in the Eli Lilly v. [read post]
5 Oct 2020, 2:05 pm
Indianapolis, Indiana – Eli Lilly and Company (“Lilly”) filed suit on November 13, 2019 in the Southern District of Indiana against Defendant SensorRx seeking a declaratory judgment that it had not misappropriated trade secrets among other things. [read post]
21 Sep 2020, 12:00 am
At the time of writing the full judgement is not available, yet.Immediately after the nullity hearing, Eli Lilly filed for preliminary injunctions against generics. [read post]
